Harlan M Krumholz
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID. (NCT05668091) | Harlan M Krumholz | 2023-04-14 |
Track Harlan M Krumholz automatically
Every clearance here is in the API, with alerts when new ones post.